Squamous Cell Non Small Cell Lung Cancer clinical trials

Explore recruiting squamous cell non small cell lung cancer clinical trials.

Recruiting squamous cell non small cell lung cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Squamous Cell Non Small Cell Lung Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Compared to Oral Lenvatinib Capsules in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Squamous Cell Non Small Cell Lung Cancer trials by city

Squamous Cell Non Small Cell Lung Cancer clinical trials

Recruiting squamous cell non small cell lung cancer studies right now

Study of GV20-0251 in Participants With Solid Tumor Malignancies

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

A Phase II Study of Sacituzumab Tirumotecan in Combination With Furmonertinib in Patients With Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based Chemotherapy

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Also recruiting in Europe

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Compared to Oral Lenvatinib Capsules in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

Squamous Cell Non Small Cell Lung Cancer trials by city

Other conditions